Sujal Shah - Net Worth and Insider Trading
Sujal Shah Net Worth
The estimated net worth of Sujal Shah is at least $6 Million dollars as of 2024-05-04. Sujal Shah is the CEO of CymaBay Therapeutics Inc and owns about 171,301 shares of CymaBay Therapeutics Inc (CBAY) stock worth over $6 Million. Details can be seen in Sujal Shah's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Sujal Shah has not made any transactions after 2023-11-13 and currently still holds the listed stock(s).
Transaction Summary of Sujal Shah
Sujal Shah Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Sujal Shah owns 1 companies in total, including CymaBay Therapeutics Inc (CBAY) .
Click here to see the complete history of Sujal Shah’s form 4 insider trades.
Insider Ownership Summary of Sujal Shah
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CBAY | CymaBay Therapeutics Inc | 2023-11-13 | director & Chief Executive Officer |
Sujal Shah Latest Holdings Summary
Sujal Shah currently owns a total of 1 stock. Sujal Shah owns 171,301 shares of CymaBay Therapeutics Inc (CBAY) as of November 13, 2023, with a value of $6 Million.
Latest Holdings of Sujal Shah
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CBAY | CymaBay Therapeutics Inc | 2023-11-13 | 171,301 | 32.48 | 5,563,856 |
Holding Weightings of Sujal Shah
Sujal Shah Form 4 Trading Tracker
According to the SEC Form 4 filings, Sujal Shah has made a total of 5 transactions in CymaBay Therapeutics Inc (CBAY) over the past 5 years, including 3 buys and 2 sells. The most-recent trade in CymaBay Therapeutics Inc is the sale of 64,863 shares on November 13, 2023, which brought Sujal Shah around $1 Million.
Insider Trading History of Sujal Shah
- 1
Sujal Shah Trading Performance
GuruFocus tracks the stock performance after each of Sujal Shah's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Sujal Shah is 6.36%. GuruFocus also compares Sujal Shah's trading performance to market benchmark return within the same time period. The performance of stocks bought by Sujal Shah within 3 months outperforms 5 times out of 10 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Sujal Shah's insider trading performs compared to the benchmark.
Performance of Sujal Shah
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 19.82 | | | | | |
| Relative Return to S&P 500(%) | 18.67 | | | | | |
Sujal Shah Ownership Network
Sujal Shah Owned Company Details
What does CymaBay Therapeutics Inc do?
Who are the key executives at CymaBay Therapeutics Inc?
Sujal Shah is the director & Chief Executive Officer of CymaBay Therapeutics Inc. Other key executives at CymaBay Therapeutics Inc include Chief Scientific Officer Charles Mcwherter , Vice President & Finance Daniel Menold , and General Counsel Paul T Quinlan .
CymaBay Therapeutics Inc (CBAY) Insider Trades Summary
Over the past 18 months, Sujal Shah made 2 insider transaction in CymaBay Therapeutics Inc (CBAY) with a net sale of 129,724. Other recent insider transactions involving CymaBay Therapeutics Inc (CBAY) include a net sale of 171,559 shares made by Charles Mcwherter , a net sale of 93,000 shares made by Paul T Quinlan , and a net sale of 52,442 shares made by Daniel Menold .
In summary, during the past 3 months, insiders sold 6,000 shares of CymaBay Therapeutics Inc (CBAY) in total and bought 0 shares, with a net sale of 6,000 shares. During the past 18 months, 601,746 shares of CymaBay Therapeutics Inc (CBAY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 601,746 shares.
CymaBay Therapeutics Inc (CBAY)'s detailed insider trading history can be found in Insider Trading Tracker table.
CymaBay Therapeutics Inc Insider Transactions
Sujal Shah Mailing Address
Above is the net worth, insider trading, and ownership report for Sujal Shah. You might contact Sujal Shah via mailing address: C/o Cymabay Therapeutics, Inc., 7575 Gateway Blvd., Suite 110, Newark Ca 94560.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
